The life sciences industry is facing significant challenges, many of which are unique to the sector. At the same time, the market as a whole is becoming more open to outsourcing, having begun to shake off the conservatism that dogged it in the first half of the last decade. Consequently, there are increasing opportunities for outsourcing vendors to make their mark in this potentially highly lucrative industry. Here we provide an overview of the issues facing the pharmaceuticals (pharma) and biotechnology (biotech) sectors and highlight a key outsourcing opportunity around the delivery of services related to the clinical research and development process.
